Marshall Wace’s Global Cord Blood Corporation CO Stock Holding History

Marshall Wace’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,332	Closed	-$12.9K	–	2893
2023 Q2	$12.9K	Hold	12,332	–	–	﹤0.01%	2391
2023 Q1	$18.5K	Hold	12,332	–	–	﹤0.01%	2577
2022 Q4	$31.7K	Hold	12,332	–	–	﹤0.01%	2856
2022 Q3	$29K	Sell	12,332 -21,018	-63%	-$51.6K	﹤0.01%	3258
2022 Q2	$98K	Buy	33,350 +16,892	+103%	+$52.4K	﹤0.01%	3281
2022 Q1	$63K	Buy	+16,458	New	+$68.3K	﹤0.01%	3233
2020 Q3	–	Sell	-36,012	Closed	-$112K	–	2105
2020 Q2	$112K	Buy	36,012 +2,661	+8%	+$7.73K	﹤0.01%	1449
2020 Q1	$106K	Sell	33,351 -5,750	-15%	-$25.1K	﹤0.01%	1305
2019 Q4	$196K	Buy	39,101 +3,592	+10%	+$17.2K	﹤0.01%	1349
2019 Q3	$172K	Buy	+35,509	New	+$186K	﹤0.01%	1309

Other funds holding CO

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return

Marshall Wace's CO Position: Q3 2023 in Review

Marshall Wace sold out of Global Cord Blood Corporation (CO) in Q3 2023, closing a stake of 12,332 shares — an estimated $12.9K sold.

Marshall Wace first reported a position in CO in Q3 2019 and held it in 10 quarters. The position peaked at $196K in Q4 2019. 2 funds tracked by Wall St. Rank hold CO as of Q3 2023.

Marshall Wace reported no remaining Global Cord Blood Corporation position as of Q3 2023 after selling out during the quarter.
Marshall Wace sold 12,332 Global Cord Blood Corporation shares in Q3 2023, an estimated $12.9K.
Marshall Wace first reported a position in Global Cord Blood Corporation in Q3 2019 and held it in 10 quarters.
Marshall Wace's Global Cord Blood Corporation position peaked at $196K in Q4 2019.
2 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.